EnsoSleep

EnsoSleep is a software medical device designed to assist clinicians by automatically analyzing and scoring adult polysomnography data to assess sleep quality and aid in diagnosing sleep-related disorders, based on AASM guidelines. Its methodology involves cloud-based algorithmic processing of physiological signals to detect sleep stages, respiratory events, arousals, and leg movements, with its efficacy and safety supported by comparative clinical performance testing against established devices.

EnsoSleep is a software-only medical device intended for physicians to assess sleep quality and aid in diagnosing sleep and respiratory-related sleep disorders in adults. It operates by analyzing previously recorded physiological signals from sleep studies, specifically EDF or EDF+ files, using automated algorithms processed on cloud servers. The software automatically scores sleep stages (Wake, N1, N2, N3, REM), detects arousals, periodic leg movements, and sleep-disordered breathing events, including obstructive apneas. However, central apneas, mixed apneas, and hypopneas require manual marking by a qualified clinician, who must also verify all automatically scored events. The core science of EnsoSleep relies on automated algorithms applying American Academy of Sleep Medicine (AASM) scoring rules to interpret raw and derived physiological signals. Key technological features include improved scoring efficiency, scalability via distributed cloud servers, fault-tolerant network protocols for enhanced reliability, and robust cybersecurity measures. Clinical performance was validated using retrospective polysomnography data from 72 subjects, comparing EnsoSleep against predicate devices. Results demonstrated that EnsoSleep achieved substantially equivalent or statistically superior performance in sleep staging, sleep apnea diagnostic agreement (for mild and moderate AHI thresholds), and detection of sleep-disordered breathing, apnea, obstructive apnea, arousal, and leg movement events.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific algorithms or machine learning approaches does EnsoSleep utilize for sleep stage and event detection, and how are these algorithms trained and validated internally beyond the reported comparative study?; The document states central apneas, mixed apneas, and hypopneas must be manually marked. What is the software's capability in flagging potential instances of these events to guide the clinician, even if final marking is manual?; How does EnsoSleep's performance in detecting obstructive apneas differ in patients with varying BMI or anatomical airway characteristics, given these factors can significantly influence OSA presentation?; Regarding the N=72 subject sample for clinical testing, what were the demographic characteristics and distribution of sleep disorder severities, and how might these affect the generalizability of the performance results?; The summary mentions 'cybersecurity improvements.' Can more specific details be provided on the encryption standards and data protection measures implemented for patient data processed on EnsoSleep cloud servers?